Imagine a “micro medical team” that is a thousand times thinner than a hair, capable of infiltrating the most delicate area of our body—the brain—to perform precise repairs on malfunctioning parts. This is no longer science fiction, but the cutting-edge exploration in the field of Parkinson’s treatment: nanobots.Introduction: Our Brain Awaits a “Minimally Invasive Revolution”Our … Read more
📚 Reference InformationTitle: Digital Dual-Dimensional α-Synuclein Aggregate Decoding Sensor for Parkinson’s Disease DiagnosticsAuthors: Yongfeng Lu, Yanling Liu, Caihong Liu et al. (2025)Journal: Advanced Functional Materials｜DOI: 10.1002/adfm.202519715 🔍 Core Issues Research Objective: To develop a dual-dimensional sensor capable of simultaneously detecting free and vesicle-bound α-synuclein aggregates in serum, enhancing the early diagnostic capability for Parkinson’s disease. … Read more
↑↑ Click on the above“MedLive Neurology” to follow us ↑↑ Dopamine Dysregulation Syndrome (DDS) is a condition characterized by compulsive use of dopaminergic medications in patients with Parkinson’s disease undergoing long-term dopamine replacement therapy (DRT), with an average onset age of around 60 years. Currently, there are few reports on the incidence of DDS, not … Read more
Written by He Yan Editor: Wang Sizhen Parkinson’s Disease (Parkinson’s Disease, PD） is a chronic progressive neurodegenerative disease, second only to Alzheimer’s disease, with its incidence increasing with the aging population【1】. PD primarily affects dopaminergic neurons in the substantia nigra pars compacta (SNc), where α-synuclein (α-Synuclein, α-Syn) accumulates, leading to neuronal death. The SNc mainly … Read more